Assessing the Value of the Quality of Health Economic Studies (QHES)
Assessing the Value of the Quality of Health Economic Studies (QHES)
复制标题
评估卫生经济研究质量（QHES）的价值
DOI：
--
复制
发表时间：
2003
影响因子：
--
通讯作者：
B. Motheral
中科院分区：
文献类型：
--
作者：
B. Motheral
选择患者(糖尿病、慢性肾功能衰竭、心肌梗死后)和联合治疗。出于研究设计的原因，没有将β-受体阻滞剂与利尿剂进行比较。有些人可能会争辩说，这些药物可能比利尿剂更具成本效益，利尿剂通常需要实验室检测和补钾。然而，对于大多数患有轻中度高血压的患者来说，利尿剂应该是控制血压和减少不良临床结果的首要或次要药物。管理型保健药剂师应该熟悉ALLHAT的研究结果，并帮助培训临床医生和P&T委员会的成员了解这些发现。
select patients (diabetes mellitus, chronic renal failure, post-MI) and in combination therapy. The beta-blockers were not compared with the diuretic for study design reasons. Some may argue that these agents may be more cost effective than the diuretics that often require laboratory testing and potassium supplementation. However, for a majority of patients with mild to moderate hypertension, a diuretic should be the initial, or perhaps second, agent chosen to control blood pressure and reduce adverse clinical outcomes. Managed care pharmacists should be familiar with the ALLHAT study findings and help educate clinicians and members of P & T committees regarding these findings.
DOI：
10.1016/0197-2456(90)90175-2
发表时间：
1990-10-01
期刊：
CONTROLLED CLINICAL TRIALS
影响因子：
--
作者：
EMERSON, JD;BURDICK, E;CHALMERS, TC
通讯作者：
CHALMERS, TC